RA Capital Management, L.P. 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 0 0.000% |
-2,850,000 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 2,850,000 5.900% |
0 (Unchanged) |
Filing |
| 2021-03-24 4:30 pm Purchase |
2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 2,850,000 6.000% |
2,850,000 (New Position) |
Filing |